Rocket Pharmaceuticals, Inc. (RCKT)

2.435 -0.18 (-6.70%) USD  |  NASDAQ  |  Nov 05, 16:00
2.40 -0.04 (-1.44%) After-Hours: 06:50
More

Rocket Pharmaceuticals SG&A Expense (TTM) : 67.52M for June 30, 2026

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 67.52M
March 31, 2026 75.11M
December 31, 2025 86.50M
September 30, 2025 97.15M
June 30, 2025 105.91M
March 31, 2025 108.26M
December 31, 2024 101.96M
September 30, 2024 98.16M
June 30, 2024 89.64M
March 31, 2024 79.64M
December 31, 2023 73.32M
September 30, 2023 70.83M
June 30, 2023 67.35M
March 31, 2023 62.83M
December 31, 2022 58.77M
September 30, 2022 51.90M
June 30, 2022 46.47M
March 31, 2022 42.86M
December 31, 2021 41.77M
September 30, 2021 37.80M
June 30, 2021 33.86M
March 31, 2021 31.44M
December 31, 2020 27.92M
September 30, 2020 24.70M
June 30, 2020 23.31M
Date Value
March 31, 2020 20.88M
December 31, 2019 17.53M
September 30, 2019 15.43M
June 30, 2019 13.36M
March 31, 2019 13.06M
December 31, 2018 17.91M
September 30, 2018 16.77M
June 30, 2018 16.33M
March 31, 2018 12.93M
December 31, 2017 4.855M
September 30, 2017 5.864M
June 30, 2017 6.344M
March 31, 2017 7.957M
December 31, 2016 9.894M
September 30, 2016 9.457M
June 30, 2016 8.971M
March 31, 2016 8.384M
December 31, 2015 7.842M
September 30, 2015 6.308M
June 30, 2015 5.326M
March 31, 2015 3.93M
December 31, 2014 2.112M
September 30, 2014 1.419M
June 30, 2014 0.797M
March 31, 2014 0.465M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. 436.74M
Intellia Therapeutics, Inc. 105.74M
Beam Therapeutics, Inc. 98.66M
Arrowhead Pharmaceuticals, Inc. 172.57M
Oncolytics Biotech, Inc. 16.62M